Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060011/S043

C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)

Rayner Intraocular Lenses , Ltd. · Decision date Dec 23, 2025

FDA DECISIONP060011/S043

What did the FDA decide?

FDA records P060011/S043 as a supplement to PMA P060011, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 23, 2025.

FDA approval order statement

a new release-and-wash-bath process to be used during the lens profiling and milling operations
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Dec 23, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P060011/S043
Regulatory pathway
PMA supplement
Product code
HQL
Decision code
OK30
Decision date
Dec 23, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

For the original device and its historical approval scope, see PMA P060011. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060011 · Original PMA

    C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)

  2. P060011/S042 · Related supplement

    Rayner C-flex 570C, C-flex Aspheric 970C, 600C Aspheric, RayOne Aspheric RAO600C, RayOne Spheric RAO100C and RayOne EMV

  3. P060011/S043 received

    Application receipt date recorded by FDA.

  4. P060011/S043 · FDA decision

    30-Day Notice

  5. P060011/S044 · Related supplement

    Rayner C-flex 570C, C-flex Aspheric 970C, 600C Aspheric Intraocular lenses, RayOne Aspheric RAO600C, RayOne Spheric RAO1

  6. P060011/S045 · Related supplement

    RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X

Timeline entries are records held by MedtechLedger for P060011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060011

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rayner Intraocular Lenses , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1-2 Sackville Trading Estate,, Sackville Rd., Hove, E. Sussex, BN3 7AN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records